1,909
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The RNA ligation method using modified splint DNAs significantly improves the efficiency of circular RNA synthesis

, , , , , & show all
Pages 208-218 | Received 03 Aug 2023, Accepted 20 Sep 2023, Published online: 04 Oct 2023

References

  • Abdelmohsen K, Panda AC, Munk R, Grammatikakis I, Dudekula DB, De S, Kim J, Noh JH, Kim KM, Martindale JL, et al. 2017. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 14(3):361–369. doi:10.1080/15476286.2017.1279788.
  • Akira S. 2012. The role of mRNA degradation in immunity and inflammation. Arthritis Res Ther. 14(1):O7. doi:10.1186/ar3562.
  • Bain JD, Switzer C. 1992. Regioselective ligation of oligoribonucleotides using DNA splints. Nucleic Acids Res. 20(16):4372–4372. doi:10.1093/nar/20.16.4372.
  • Buckley KM, Yoder JA. 2022. The evolution of innate immune receptors: investigating the diversity, distribution, and phylogeny of immune recognition across eukaryotes. Immunogenetics. 74(1):1–4. doi:10.1007/s00251-021-01243-4.
  • Chaudhary N, Weissman D, Whitehead KA. 2021. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov. 20(11):817–838. doi:10.1038/s41573-021-00283-5.
  • Chen C-Y, Sarnow P. 1995. Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 268(5209):415–417. doi:10.1126/science.7536344.
  • Chen J, Sun Y, Huang S, Shen H, Chen Y. 2021. Grub polypeptide extracts protect against oxidative stress through the NRF2-ARE signaling pathway. Anim Cells Syst. 25(6):405–415. doi:10.1080/19768354.2021.2018043.
  • Cristofalo M, Kovari D, Corti R, Salerno D, Cassina V, Dunlap D, Mantegazza F. 2019. Nanomechanics of diaminopurine-substituted DNA. Biophys J. 116(5):760–771. doi:10.1016/j.bpj.2019.01.027.
  • Crommelin DJA, Anchordoquy TJ, Volkin DB, Jiskoot W, Mastrobattista E. 2021. Addressing the cold reality of mRNA vaccine stability. J Pharm Sci. 110(3):997–1001. doi:10.1016/j.xphs.2020.12.006.
  • Enuka Y, Lauriola M, Feldman ME, Sas-Chen A, Ulitsky I, Yarden Y. 2016. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res. 44(3):1370–1383. doi:10.1093/nar/gkv1367.
  • Fang Y, Wang X, Li W, Han J, Jin J, Su F, Zhang J, Huang W, Xiao F, Pan Q, et al. 2018. Screening of circular RNAs and validation of circANKRD36 associated with inflammation in patients with type 2 diabetes mellitus. Int J Mol Med. 42(4):1865–1874. Eng.
  • Ford E, Ares M Jr. 1994. Synthesis of circular RNA in bacteria and yeast using RNA cyclase ribozymes derived from a group I intron of phage T4. Proc Natl Acad Sci USA. 91(8):3117–3121. Eng. doi:10.1073/pnas.91.8.3117.
  • Frederickson R, Herzog RW. 2021. RNA-based vaccines and innate immune activation: not too hot and not too cold. Mol Ther. 29(4):1365–1366. doi:10.1016/j.ymthe.2021.03.005.
  • Gholamalipour Y, Karunanayake Mudiyanselage A, Martin CT. 2018. 3’ end additions by T7 RNA polymerase are RNA self-templated, distributive and diverse in character-RNA-seq analyses. Nucleic Acids Res. 46(18):9253–9263. doi:10.1093/nar/gky796.
  • Hanan M, Soreq H, Kadener S. 2017. CircRNAs in the brain. RNA Biol. 14(8):1028–1034. doi:10.1080/15476286.2016.1255398.
  • Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, Kjems J. 2013. Natural RNA circles function as efficient microRNA sponges. Nature. 495(7441):384–388. doi:10.1038/nature11993.
  • Hawash MBF, Sanz-Remon J, Grenier JC, Kohn J, Yotova V, Johnson Z, Lanford RE, Brinkworth JF, Barreiro LB. 2021. Primate innate immune responses to bacterial and viral pathogens reveals an evolutionary trade-off between strength and specificity. Proc Natl Acad Sci USA. 118(13):e2015855118. doi:10.1073/pnas.2015855118.
  • He AT, Liu J, Li F, Yang BB. 2021. Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther. 6(1):185. doi:10.1038/s41392-021-00569-5.
  • Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, et al. 2016. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 7:12429. doi:10.1038/ncomms12429.
  • Hsu M-T, Coca-Prados M. 1979. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 280(5720):339–340. doi:10.1038/280339a0.
  • Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, Marzluff WF, Sharpless NE. 2013. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 19(2):141–157. doi:10.1261/rna.035667.112.
  • Jung H, Kim YS, Jung DM, Lee KS, Lee JM, Kim KK. 2022. Melittin-derived peptides exhibit variations in cytotoxicity and antioxidant, anti-inflammatory and allergenic activities. Anim Cells Syst. 26(4):158–165. doi:10.1080/19768354.2022.2099971.
  • Kershaw CJ, O'Keefe RT. 2012. Splint ligation of RNA with T4 DNA ligase. Methods Mol Biol. 941:257–269. doi:10.1007/978-1-62703-113-4_19.
  • Korosec CS, Farhang-Sardroodi S, Dick DW, Gholami S, Ghaemi MS, Moyles IR, Craig M, Ooi HK, Heffernan JM. 2022. Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. Sci Rep. 12(1):21232. doi:10.1038/s41598-022-25134-0.
  • Kozak M. 1979. Inability of circular mRNA to attach to eukaryotic ribosomes. Nature. 280(5717):82–85. doi:10.1038/280082a0.
  • Kristensen LS, Hansen TB, Veno MT, Kjems J. 2018. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 37(5):555–565. doi:10.1038/onc.2017.361.
  • Li H, Li K, Lai W, Li X, Wang H, Yang J, Chu S, Wang H, Kang C, Qiu Y. 2018. Comprehensive circular RNA profiles in plasma reveals that circular RNAs can be used as novel biomarkers for systemic lupus erythematosus. Clin Chim Acta. 480:17–25. doi:10.1016/j.cca.2018.01.026.
  • Liu CX, Guo SK, Nan F, Xu YF, Yang L, Chen LL. 2022. RNA circles with minimized immunogenicity as potent PKR inhibitors. Mol Cell. 82(2):420–434 e426. doi:10.1016/j.molcel.2021.11.019.
  • Moore MJ, Query CC. 2000. [7] Joining of RNAs by splinted ligation. Methods Enzymol. 317:109–123. doi:10.1016/S0076-6879(00)17009-0.
  • Obi P, Chen YG. 2021. The design and synthesis of circular RNAs. Methods. 196:85–103. doi:10.1016/j.ymeth.2021.02.020.
  • Puttaraju M, Been MD. 1992. Group I permuted intron-exon (PIE) sequences self-splice to produce circular exons. Nucleic Acids Res. 20(20):5357–5364. Eng. doi:10.1093/nar/20.20.5357.
  • Qin K, Zhang F, Wang H, Wang N, Qiu H, Jia X, Gong S, Zhang Z. 2023. circRNA circSnx12 confers cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis. BMB Rep. 56(2):184–189.
  • Qu L, Yi Z, Shen Y, Lin L, Chen F, Xu Y, Wu Z, Tang H, Zhang X, Tian F, et al. 2022. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell. 185(10):1728–1744 e1716. doi:10.1016/j.cell.2022.03.044.
  • Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. 1976. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA. 73(11):3852–3856. doi:10.1073/pnas.73.11.3852.
  • Stark MR, Rader SD. 2014. Efficient splinted ligation of synthetic RNA using RNA ligase. Methods Mol Biol. 1126:137–149. doi:10.1007/978-1-62703-980-2_10.
  • Stoll L, Sobel J, Rodriguez-Trejo A, Guay C, Lee K, Veno MT, Kjems J, Laybutt DR, Regazzi R. 2018. Circular RNAs as novel regulators of beta-cell functions in normal and disease conditions. Mol Metab. 9:69–83. doi:10.1016/j.molmet.2018.01.010.
  • Sun H, Zhang Y, Wang G, Yang W, Xu Y. 2023. mRNA-based therapeutics in cancer treatment. Pharmaceutics. 15(2):622. doi:10.3390/pharmaceutics15020622.
  • Uddin MN, Roni MA. 2021. Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines. 9(9):1033. doi:10.3390/vaccines9091033.
  • Wesselhoeft RA, Kowalski PS, Anderson DG. 2018. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun. 9(1):2629. doi:10.1038/s41467-018-05096-6.
  • Wesselhoeft RA, Kowalski PS, Parker-Hale FC, Huang Y, Bisaria N, Anderson DG. 2019. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol Cell. 74(3):508–520 e504. doi:10.1016/j.molcel.2019.02.015.